IVD Firms Report Strong Growth Because of COVID-19 Testing

By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue

TO NO ONE’S SURPRISE, THOSE IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS that produce molecular tests, instruments, and automation used for COVID-19 testing reported strong growth in revenue and profits during 2020.  In recent weeks, these companies issued t…

Read More

---

2020’s Top 10 Lab Stories Are Without Precedent!

By Robert Michel | From the Volume XXVII, No. 18 – December 28, 2020 Issue

CEO SUMMARY: There are several surprises in The Dark Report’s list of the Top 10 Lab Stories for 2020. Despite the SARS-CoV-2 pandemic dominating every aspect of clinical care, social…

Read More

---

Biggest IVD Manufacturers Report Robust Third Quarter Earnings

By Robert Michel | From the Volume XXV No. 15 – October 22, 2018 Issue

In a time of shrinking lab budgets and falling prices for lab tests in the United States, how are the larger in vitro diagnostic (IVD) manufacturers doing? A look at third-quarter financial reports provides useful insights as to which segments within the IVD industry are doing better than ot…

Read More

---

More IVD Consolidation as Danaher Acquires Iris

By Joseph Burns | From the Volume XIX No. – October 8, 2012 Issue

CEO SUMMARY: Danaher Corporation continues to fuel growth by continually acquiring in vitro diagnostics (IVD) companies. Its latest purchase is Iris International, which manufactures automated urine microscopy systems. Danaher also has $5 billion available that it could spend in the next …

Read More

---

September 13, 2010 “Intelligence: Late Breaking Lab News”

By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue

Researchers at North Carolina State University are developing a method that might make it possible to diagnose and treat cancer through the use of special microneedles they developed. NCSU researchers use the microneedles to deliver nanoscale dyes based on quantum dots to locations u…

Read More

---

Olympus Diagnostics Unit Sold to Beckman Coulter

By Robert Michel | From the Volume XVI No. 4 – March 16, 2009 Issue

CEO SUMMARY: For Beckman Coulter, the opportunity to acquire the diagnostics business of Olympus Corporation was compelling for at least two reasons. One, the chemistry and automation products of both companies are quite complementary. Two, in a steadily-consolidating in vitro di…

Read More

---

Busy Year Demonstrated By Top Ten Lab Stories

By Robert Michel | From the Volume XIV No. 17 – December 10, 2007 Issue

CEO SUMMARY: As it turns out, 2007 has been an action-packed year with lots of events, plenty of changes, and the promise of even faster evolution across all sectors of the lab testing marketplace. THE D…

Read More

---

Siemens Acquires Dade, Builds IVD Powerhouse

By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue

CEO SUMMARY: In just 15 months, Siemens AG has pulled out its checkbook three times to spend more than $14 billion to acquire major in vitro diagnostics (IVD) companies. When it closes the purchase of Dade Behring, Siemens will be in the first rank of global IVD manufacturers. It has also…

Read More

---

Misys Health Restructures By Selling Two Divisions

By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue

CEO SUMMARY: Misys Healthcare Systems of London, England, has sold its diagnostic LIS systems to Vista Equity Partners of San Francisco, California, for $381.5 million. The deal raises several questions, particularly for those labs currently running Misys laboratory information systems (L…

Read More

---

GE’s Deal for Abbott IVD Collapses Last Week

By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue

CEO SUMMARY: Both companies have said little about their mutual decision, announced last week, to kill the pending sale of Abbott Diagnostics and Point-of-Care businesses to General Electric. One probability is that GE decided, during due diligence, that its willingness to pay a premium p…

Read More

---